Jazz Pharmaceuticals' Lung Cancer Setback: Stock Impact
A late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
Evaluate after-tax yields across bond options in retirement to determine which bond yields the most income after taxes.
26,078 articlesA late-stage setback for Jazz Pharmaceuticals' lung cancer drug Zepzelca rattled investors, but the larger story may ...
A new study links AI spending to increased hiring in large U.S. firms, suggesting productivity gains precede payroll ...
Micron Technology fell about 8% in Wednesday trading as investors priced in rising competition from Chinese memory ma...
Quantum investing is no longer a dream. This practical guide weighs D-Wave Quantum’s potential, the risks, and steps ...
Meta Platforms surprised the market on Wednesday as investors rallied around news of new paid tier options and a broa...
AMD and Palantir posted contrasting Q1 2026 results, underscoring hardware-led AI growth versus enterprise software a...
As AI expands from novelty to durable demand, investors wonder if the AI trade is entering its second wave. This arti...
A fabless chip ETF is up sharply this year, powered by AI-driven design firms and a deliberate omission of Intel. The...
A pivotal AI funding milestone shifts how investors view tech giants. Learn what the Anthropic move signals for Amazo...
A surge in Lemonade's stock grabbed attention as investors weighed renewed reinsurance terms and AI-driven growth. Th...
Progressive isn’t just selling policies; it’s harnessing driving data to price risk more precisely. That quiet edge c...
When a wedding invite becomes news, boundaries matter. This article analyzes the simone biles sharpest answer and sho...